Inherited genetic trait predicts resistance to immunotherapy for deadly skin cancer

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune checkpoint inhibitors. Metastatic melanoma, as the disease is formally named, kills nearly 10,000 Americans annually.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup